Skip to main content

Advertisement

SpringerLink
Log in

Cardiac Sarcoidosis

  • Congestive Heart Failure (J Lindenfeld, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Cardiac sarcoidosis (CS) is a rare and under-recognized clinical entity that requires a high level of suspicion and low threshold for screening in order to make the diagnosis. CS may manifest in a variety of ways, and its initial presentation can range from asymptomatic electrocardiographic abnormalities to overt heart failure to sudden cardiac death. The aim of this literature review is to provide a comprehensive overview of CS, with an emphasis on clinical manifestations and special diagnostic and management considerations, while highlighting recent studies that have provided new insights into this unique disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DLT, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine. 2004;83:315–34.

    Article  PubMed  Google Scholar 

  2. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT, Prystowsky EN, et al. Cardiac sarcoidosis. Am Heart J. 2009;157:9–21.

    Article  CAS  PubMed  Google Scholar 

  3. Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivistö SM, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011;270:461–8.

    Article  CAS  PubMed  Google Scholar 

  4. Yazaki Y, Isobe M, Hiroe M, Morimoto S-I, Hiramitsu S, Nakano T, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol Elsevier. 2001;88:1006–10.

    Article  CAS  Google Scholar 

  5. Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–41.

    Article  CAS  PubMed  Google Scholar 

  6. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224–34.

    Article  CAS  PubMed  Google Scholar 

  7. Hosoda Y, Yamaguchi M, Hiraga Y. Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? Clin Chest Med. 1997;18:681–94.

    Article  CAS  PubMed  Google Scholar 

  8. Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984;130:29–32.

    CAS  PubMed  Google Scholar 

  9. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204–11.

    Article  CAS  PubMed  Google Scholar 

  10. Tachibana T, Iwai K, Takemura T. Study on cause of death in the patients with sarcoidosis in Japan. Sarcoidosis Sigilim SRL. 1992;9:307–7.

    Google Scholar 

  11. Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976;278:455–69.

    Article  CAS  PubMed  Google Scholar 

  12. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–30.

    PubMed  Google Scholar 

  13. Eishi Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by propionibacterium acnes. BioMed Res Int. 2013;2013:1–18.

    Article  Google Scholar 

  14. Tchernev G, Ananiev J, Cardoso JC, Wollina U, Verma SB, Patterson JW, et al. Sarcoidosis and molecular mimicry—important etiopathogenetic aspects: current state and future directions. Wien Klin Wochenschr Springer. 2012;124:227–38.

    Article  Google Scholar 

  15. Baughman RP, Lower EE, Bois du RM. Sarcoidosis. Lancet. 2003;361:1111–8.

    Article  CAS  PubMed  Google Scholar 

  16. Schürmann M, Lympany PA, Reichel P, Müller-Myhsok B, Wurm K, Schlaak M, et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med. 2000;162:861–4.

    PubMed  Google Scholar 

  17. Doughan AR. Cardiac sarcoidosis. Heart. 2006;92:282–8.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63:86–108.

    Article  CAS  PubMed  Google Scholar 

  19. Navaneethan SD, Venkatesh S, Shrivastava R, Mehta J, Israel R. Recurrent pleural and pericardial effusions due to sarcoidosis. PLoS Med. 2005;2:e63.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Sekhri V, Sanal S, DeLorenzo LJ, Aronow WS, Maguire GP. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci. 2011;4:546–54.

    Article  Google Scholar 

  21. Schuller JL, Lowery CM, Zipse M, Aleong RG, Varosy PD, Weinberger HD, et al. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16:70–6.

    Article  PubMed  Google Scholar 

  22. Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace. 2013;15:347–54. A multicenter retrospective review which represents the largest published cohort of cardiac sarcoidosis patients with ICDs.

    Article  PubMed  Google Scholar 

  23. Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2012;23:925–9. One of three 2012 studies of CS patients with ICDs. No primary prevention patients with normal LV and RV function received an appropriate therapy for VT.

    Article  PubMed  Google Scholar 

  24. Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DLT, et al. Cardiac sarcoidosis. Medicine. 2004;83:315–34.

    Article  PubMed  Google Scholar 

  25. Schuller JL, Olson MD, Zipse MM, Schneider PM, Aleong RG, Wienberger HD, et al. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J Cardiovasc Electrophysiol. 2011;22:1243–8.

    Article  PubMed  Google Scholar 

  26. Yoshida Y, Morimoto S, Hiramitsu S, Tsuboi N, Hirayama H, Itoh T. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J. 1997;134:382–6.

    Article  CAS  PubMed  Google Scholar 

  27. Gozo EG, Cosnow I, Cohen HC, Okun L. The heart in sarcoidosis. Chest Am Coll Chest Phys. 1971;60:379–88.

    Google Scholar 

  28. Abeler V. Sarcoidosis of the cardiac conducting system. Am Heart J. 1979;97:701–7.

    Article  CAS  PubMed  Google Scholar 

  29. Ton K, Schulman S, Lima J, Tandri H. Cardiac Sarcoidosis Presenting as Sick Sinus Syndrome and Recurrent Ventricular Tachycardia. HRS 2014. 2014. pp. 1–1.

  30. Zipse MM, Schuller JL, Katz DF, Steckman DA, Gonzalez JE, Sung RK, et al. Atrial Arrhythmias are Common and Arise from Diverse Mechanisms in Patients with Cardiac Sarcoidosis. Heart Rhythm 2013. 2013. pp. 1–2.

  31. Viles-Gonzalez JF, Pastori L, Fischer A, Wisnivesky JP, Goldman MG, Mehta D. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest. 2013;143:1085–90. The first retrospective study of atrial arrhythmias in CS.

    Article  PubMed  Google Scholar 

  32. Cain MA, Metzl MD, Patel AR, Addetia K. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias. Am J Cardiol. 2014;113(9):1556–60.

    Article  PubMed  Google Scholar 

  33. Winters SL, Cohen M, Greenberg S, Stein B, Curwin J, Pe E, et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. JAC. 1991;18:937–43.

    Article  CAS  Google Scholar 

  34. Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. HRTHM. 2006;3:924–9.

    Google Scholar 

  35. Jefic D, Joel B, Good E, Morady F, Rosman H, Knight B, et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm. 2009;6:189–95.

    Article  PubMed  Google Scholar 

  36. Banba K, Kusano KF, Nakamura K, Morita H, Ogawa A, Ohtsuka F, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. HRTHM. 2007;4:1292–9.

    Google Scholar 

  37. Furushima H, Chinushi M, Sugiura H, Kasai H, Washizuka T, Aizawa Y. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol. 2004;27:217–22.

    Article  PubMed  Google Scholar 

  38. Fleming HA, Bailey SM. Sarcoid heart disease. J R Coll Physicians Lond. 1981;15:245.

    CAS  PubMed  Google Scholar 

  39. Uusimaa P, Ylitalo K, Anttonen O, Kerola T, Virtanen V, Pääkkö E, et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace. 2008;10:760–6.

    Article  PubMed  Google Scholar 

  40. Stees CS, Khoo MSC, Lowery CM, Sauer WH. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2011;22:210–3.

    PubMed  Google Scholar 

  41. Schulte W, Kirsten D, Drent M, Costabel U. Cardiac involvement in sarcoidosis. Eur Respir Monogr Eur Respir Soc. 2005;32:130.

    Google Scholar 

  42. Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol. 2009;20:578–83. Wiley Online Library.

    Article  PubMed  Google Scholar 

  43. Hamzeh NY. Management of cardiac sarcoidosis in the United States. Chest. 2012;141:154.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Youssef G, Beanlands RSB, Birnie DH, Nery PB. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart. 2011;97:2078–87.

    Article  PubMed  Google Scholar 

  45. Yeboah J, Lee C, Sharma OP. Cardiac sarcoidosis. Curr Opin Pulm Med. 2011;17:308–15.

    Article  PubMed  Google Scholar 

  46. Nery PB, Leung E, Birnie DH. Arrhythmias in cardiac sarcoidosis. Curr Opin Cardiol. 2012;27:181–9.

    Article  PubMed  Google Scholar 

  47. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999. pp. 736–55.

  48. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:75–86.

    CAS  PubMed  Google Scholar 

  49. Lubitz SA, Goldbarg SH, Mehta D. Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis. Prog Cardiovasc Dis. 2008;51:58–73.

    Article  PubMed  Google Scholar 

  50. Nery PB, Beanlands RS, Nair GM, Green M, Yang J, Mc Ardle BA, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014. doi:10.1111/jce.12401. This study reports a high incidence of cardiac sarcoidosis in young patients with initially-unexplained AV block.

    PubMed  Google Scholar 

  51. Nery PB, Mc Ardle BA, Redpath CJ, Leung E, Lemery R, Dekemp R, et al. Prevalence of Cardiac Sarcoidosis in Patients Presenting with Monomorphic Ventricular Tachycardia. Pacing and Clinical Electrophysiology. 2013.:n/a–n/a.

  52. Ward EV, Nazari J, Edelman RR. Coronary artery vasculitis as a presentation of cardiac sarcoidosis. Circulation. 2012;125:e344–6.

    Article  PubMed  Google Scholar 

  53. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythmia Electrophysiol. 2011;4:303–9.

    Article  Google Scholar 

  54. Blauwet LA, Cooper LT. Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev. 2012;18:733–46.

    Article  Google Scholar 

  55. Chia P-L, Subbiah RN, Kuchar D, Walker B. Cardiac sarcoidosis masquerading as arrhythmogenic right ventricular cardiomyopathy. Heart Lung Circ. 2012;21:42–5.

    Article  PubMed  Google Scholar 

  56. Vasaiwala SC, Finn C, Delpriore J, Leya F, Gagermeier J, Akar JG, et al. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol. 2009;20:473–6.

    Article  PubMed  Google Scholar 

  57. Mohsen A, Panday M, Wetherold S, Jimenez A. Cardiac sarcoidosis mimicking arrhythmogenic right ventricular dysplasia with high defibrillation threshold requiring subcutaneous shocking coil implantation. Heart Lung Circ. 2012;21:46–9.

    Article  PubMed  Google Scholar 

  58. Aggeli C, Felekos I, Tousoulis D, Gialafos E, Rapti A, Stefanadis C. Myocardial mechanics for the early detection of cardiac sarcoidosis. Int J Cardiol Elsevier Irel Ltd. 2013;168:4820–1.

    Google Scholar 

  59. Suzuki T, Kanda T, Kubota S, Imai S, Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest. 1994;106:1021–4.

    Article  CAS  PubMed  Google Scholar 

  60. Adamson P, Melton I, O'Donnell J, MacDonald S, Crozier I. Cardiac sarcoidosis: the Christchurch experience. Int Med J. 2014;44:70–6.

    Article  CAS  Google Scholar 

  61. Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, et al. The diagnostic pathway to sarcoidosis. Chest. 2003;123:406–12.

    Article  PubMed  Google Scholar 

  62. Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J Elsevier. 2005;150:459–63.

    Article  Google Scholar 

  63. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299–302.

    Article  CAS  PubMed  Google Scholar 

  64. Nery PB, Keren A, Healey J, Leug E, Beanlands RS, Birnie DH. Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. Can J Cardiol. 2013;29(1015):e1–3. Describes the by which electroanatomical mapping can guide endomyocardial biopsy to improve diagnostic yield.

    Google Scholar 

  65. Pieroni M, Russo Dello A, Marzo F, Pelargonio G, Casella M, Bellocci F, et al. High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy. JAC Am Coll Cardiol Found. 2009;53:681–9.

    Article  Google Scholar 

  66. Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63:329–36.

    Article  PubMed  Google Scholar 

  67. Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging Springer. 2008;35:933–41.

    Article  Google Scholar 

  68. Vignaux O, Dhote R, Duboc D, Blanche P, Dusser D, Weber S, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest. 2002;122:1895–901.

    Article  PubMed  Google Scholar 

  69. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther. 1996;10:495–510.

    Article  CAS  PubMed  Google Scholar 

  70. Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JCMG Elsevier Inc. 2013;6:501–11.

    Google Scholar 

  71. Ishimaru S, Tsujino I, Sakaue S, Oyama N, Takei T, Tsukamoto E, et al. Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22:234–5.

    PubMed  Google Scholar 

  72. Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012;53:241–8.

    Article  CAS  PubMed  Google Scholar 

  73. Pandya C, Brunken RC, Tchou P, Schoenhagen P, Culver DA. Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques. Eur Respir J. 2007;29:418–22.

    Article  CAS  PubMed  Google Scholar 

  74. Mehta D, Mori N, Goldbarg SH, Lubitz S, Wisnivesky JP, Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythmia Electrophysiol. 2011;4:43–8.

    Article  Google Scholar 

  75. Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol. 2005;96:276–82.

    Article  PubMed  Google Scholar 

  76. Baughman RP, Ohmichi M, Lower EE. Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2001;18:133–7.

    CAS  PubMed  Google Scholar 

  77. Baughman RP, Costabel U, du RM B. Treatment of sarcoidosis. Clin Chest Med. 2008;29:533–48. x–x.

    Article  PubMed  Google Scholar 

  78. Baughman RP, Drent M, Kavuru M, JUDSON MA, Costabel U, du Bois R, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174:795–802.

    CAS  PubMed  Google Scholar 

  79. Mantini N, Williams Jr B, Stewart J, Rubinsztain L, Kacharava A. Cardiac sarcoid: a clinician’s review on how to approach the patient with cardiac sarcoid. Clin Cardiol. 2012;35:410–5.

    Article  PubMed  Google Scholar 

  80. Chiu C-Z, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol. 2005;95:143–6.

    Article  CAS  PubMed  Google Scholar 

  81. Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16:140–7.

    Article  PubMed  Google Scholar 

  82. Yodogawa K, Seino Y, Shiomura R, Takahashi K, Tsuboi I, Uetake S, et al. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. J Cardiol. 2013;62:320–5.

    Article  PubMed  Google Scholar 

  83. Sadek MM, Yung D, Birnie DH, BEANLANDS RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol. 2013;29:1034–41.

    Article  PubMed  Google Scholar 

  84. Kato Y, Morimoto S-I, Uemura A, Hiramitsu S, Ito T, Hishida H. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:133–7.

    PubMed  Google Scholar 

  85. Mohsen A, Jimenez A, Hood RE, Dickfeld T, Saliaris A, Shorofsky S, et al. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol. 2013.

  86. Zipse MM, Sauer WH. Electrophysiologic manifestations of cardiac sarcoidosis. Curr Opin Pulm Med. 2013;19:485–92.

    Article  PubMed  Google Scholar 

  87. Writing Committee Members, Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American college of cardiology/american heart association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons. Circulation. 2008;117:2820–40.

    Article  Google Scholar 

  88. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.

    Article  CAS  PubMed  Google Scholar 

  89. Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM, et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant. 1992;11:367–9.

    CAS  PubMed  Google Scholar 

  90. Yager JEE, Hernandez AF, Steenbergen C, Persing B, Russell SD, Milano C, et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant. 2005;24:1988–90.

    Article  PubMed  Google Scholar 

  91. Milman N, Andersen CB, Mortensen SA, Sander K. Cardiac sarcoidosis and heart transplantation: a report of four consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:51–9.

    CAS  PubMed  Google Scholar 

  92. Zaidi AR, Zaidi A, Vaitkus PT. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transpl Elsevier. 2007;26:714–7.

    Article  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Matthew M. Zipse and William H. Sauer declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Division of Cardiology, Section of Cardiac Electrophysiology, University of Colorado, Denver, CO, USA

    Matthew M. Zipse & William H. Sauer

  2. Section of Cardiac Electrophysiology, University of Colorado Hospital, 12401 East 17th Avenue, B136, Aurora, CO, 80045, USA

    Matthew M. Zipse & William H. Sauer

Authors
  1. Matthew M. Zipse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William H. Sauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William H. Sauer.

Additional information

This article is part of the Topical Collection on Congestive Heart Failure

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zipse, M.M., Sauer, W.H. Cardiac Sarcoidosis. Curr Cardiol Rep 16, 514 (2014). https://doi.org/10.1007/s11886-014-0514-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-014-0514-3

Keywords

Search

Navigation